The invariant chain derived fragment clip is an efficient in vitro inhibitor of peptide binding to MHC class II molecules

Molecular Immunology

Volumn 33, Issue 1, 1996, Pages 25-31

  Hitzel, Christoph ^a   Koch, Norbert ^b  

^a UNIVERSITY OF BONN   (Germany)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

CLIP; DR3; Invariant chains

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 65; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALIA;

EID: 0029933316     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00131-X     Document Type: Article

References (38)

1. Adorini L., Appella E., Doria G., Cardinaux F. and Nagy Z. A. (1989) Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature 342, 800-803.
2. Bakke O. and Dobberstein B. (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
3. Blum J. S. and Cresswell P. (1988) Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. natn. Acad. Sci. USA 85, 3975-3979.
4. Chervonsky A. and Sant A. J. (1995) In the absence of major histocompatibility complex class II molecules, invariant chain is translocated to late endocytic compartments by autophagy. Eur. J. Immun. 25, 911-918.
5. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. A. and Strominger J. L. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764-768.
6. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A. A., Lane W. S. and Strominger J. L. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178, 27-47.
7. Denzin L. K. and Cresswell P. (1995) HLA-DM induces CLIP dissociation from class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
8. Fling S. P., Arp B. and Pious D. (1994) HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554-558.
9. Freisewinkel I. M., Schenck K. and Koch N. (1993) The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. natn. Acad. Sci USA 90, 9703-9706.
10. Gautam A. M., Pearson C., Quinn V., McDevitt H. O. and Milburn P. J. (1995) Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. Proc. natn. Acad. Sci USA 92, 335-339.
11. Geluk A., Bloemhoff W. R., de Vries R. P. and Ottenhoff T. H. M. (1992) Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17 (DR3) molecules. Eur. J. Immun. 22, 107-113.
12. Harding C. V., Roof R. W. and Unanue E. R. (1989) Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: Biosynthetic turnover of Ia vs. peptide exchange. Proc. natn. Acad. Sci USA 86, 4230-4234.
13. Henne C., Schwenk F., Koch N. and Möller P. (1995) Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 84, 177-182.
14. Hitzel C., van Endert P. and Koch N. (1995) Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain. J. Immun. 154, 1048-1056.
15. d. Science 256, 1817-1820.
16. Karlsson L., Peleraux A., Lindstedt R., Liljedahl M. and Peterson P.A. (1994) Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266, 1569-1573.
17. Koch N., Moldenhauer G. and Möller P. (1991) Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J. Immun. 147, 2643-2651.
18. de Kroon A. I. P. M. and McConnell H. M. (1994) Kinetics and specificity of peptide-MHC class II complex displacement reactions. J. Immun. 152, 609-619.
19. Kvist S., Wiman K., Claesson L., Peterson P. A. and Dobberstein B. (1982) Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens Cell 29, 61-69.
20. Lanzavecchia A., Reid P. A. and Watts C. (1992) Irreversible association of peptides with class II MHC molecules in living cells. Nature 357, 249-252.
21. Malcherek G., Gnau V., Jung G., Rammensee H.-G. and Melms A. (1995) Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J. Exp. Med. 181, 527-536.
22. Merrifield R. B. (1964) Solid-phase peptide synthesis III. An improved synthesis of bradykinin. Biochemistry 3, 1385-1390.
23. Morris P., Shaman J., Attaya M., Amaya M., Goodman S., Bergman C., Monaco J. J. and Mellins E. (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
24. Nelson C. A., Petzold S. J. and Unanue E. R. (1994) Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250-252.
25. Novell J. and Quaranta V. (1985) Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (τ) chains from α-β dimers in B cells. J. Exp. Med. 162, 1371-1376.
26. Pedrazzini T., Sette A., Albertson M. and Grey H. M. (1991) Free ligand-induced dissociation of MHC-antigen complexes. J. Immun. 146, 3496-3501.
27. Pesando J. M. and Graf L. (1986) Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells. J. Immun. 136, 4311-4318.
28. Reay P. A., Wettstein D. A. and Davis M. M. (1992) pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 11, 2829-2839.
29. Riberdy J. M., Newcomb J. R., Surman M. J., Barbosa J. A. and Cresswell P. (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-477.
30. Roche P. A. and Cresswell P. (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.
31. Rudensky A. Y., Preston-Hurlburt P., Al-Ramadi B. K., Rothbard J. and Janeway C. A. (1992) Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359, 429-431.
32. Sanderson F., Kleijmeer M. J., Kelly A., Verwoerd D., Tulp A., Neefjes J. J., Geuze H. J. and Trowsdale J. (1994) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
33. Sette A., Southwood S., Miller J. and Appella E. (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181, 677-683.
34. Sloan V. S., Cameron P., Porter G., Gammon M.. Amaya M., Mellins E. and Zaller D. M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
35. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L. and Wiley D. C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
36. Trautschold I., Werle E. and Zickgraf-Rudel G. (1967) Trasylol. Biochem. Pharm. 16, 59-72.
37. Urban R. G., Chicz R. M. and Strominger J. L. (1994) Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med. 180, 751-755.
38. Watanabe M., Suzuki T., Taniguchi M. and Shinohara N. (1983) Monoclonal anti-Ia murine alloantibodies cross-reactive with the Ia-homologues of other mammalian species including humans. Transplantation 36, 712-718.